Delivery Order SPE2DB22D3016-SPE2DB25FATG2
Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a medication used to treat non-small cell lung cancer. The contract has a ceiling value of $10,662.57 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Tagrisso 40 mg tablet 30s, a medication used to treat non-small cell lung cancer. The contract has a ceiling value of $21,282.14 and a completion date of June 10, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $31,987.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a medication used to treat certain types of lung cancer. The contract is a firm fixed-price delivery order with a performance period extending through May 28, 2025. It is not designated as a set-aside contract, indicating open...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tagrisso 80 mg tablets, with a ceiling value of $42,650.28 and a period of performance through July 21, 2025. The contract is not set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of Tagrisso 80 mg tablets, a specialty pharmaceutical product. The award has a ceiling value of $21,077.60 and a completion date of April 12, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp also holds an...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor in the United States. The contract is for the supply of the prescription drug Tagrisso 80 mg tablets, which are used to treat a specific type of non-small cell lung cancer. The contract has a ceiling value of $10,538.79 and runs through September 24, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $12.4M to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price delivery order, awarded on January 7, 2026, with an ultimate completion date of January 29, 2026, represents a non-set-aside competitive award. Tagrisso is a prescription oncology medication used in the treatment of non-small cell lung cancer. The contract will be performed at AmerisourceBergen's corporate office...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,662.57, is for the delivery of Tagrisso 80 mg tablets, a medication used in cancer treatment. The contract has a firm fixed price and an ultimate completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $10,662.57 and a firm fixed price structure. This delivery order, issued under a competitive, non-set-aside procurement, is scheduled for completion by October 16, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Tagrisso is a targeted cancer therapy...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Tagrisso 80 mg tablets (quantity: 30-count packages) with a ceiling value of $21,303.64. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a prescription oncology medication used in...